| Date Filed | Type | Description |
| 06/24/2022 |
4
| Krop Julie (Director) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $0.7132, valued at
$17.8k
|
|
| 06/17/2021 |
4
| Krop Julie (Director) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $4.04, valued at
$80.8k
|
|
| 03/15/2021 |
4
| Krop Julie (Director) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 28,500 options to buy
@ $5.3, valued at
$151.1k
|
|
| 02/19/2021 |
3
| Krop Julie (Director) has filed a Form 3 on Aquestive Therapeutics, Inc. |
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/29/2019 |
4
| Krop Julie (Chief Medical Officer) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Bought 10,000 shares
@ $9.91, valued at
$99.1k
|
|
| 03/05/2019 |
4
| Krop Julie (Chief Medical Officer) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Paid exercise price by delivering 960 shares
@ $14.76, valued at
$14.2k
Paid exercise price by delivering 1,247 shares
@ $14.76, valued at
$18.4k
|
|
| 02/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2018 |
4
| Krop Julie (Chief Medical Officer) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Paid exercise price by delivering 2,161 shares
@ $19.85, valued at
$42.9k
|
|
| 03/06/2018 |
4
| Krop Julie (EVP, CMO) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Granted 13,000 shares
@ $0
Granted 12,000 shares
@ $0
Paid exercise price by delivering 1,700 shares
@ $21, valued at
$35.7k
Granted 22,000 options to buy
@ $21, valued at
$462k
|
|
| 07/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/20/2016 |
4
| Krop Julie (SVP Clinical & Regulatory, CMO) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Sold 4,938 shares
@ $24.8, valued at
$122.5k
|
|
| 06/02/2016 |
4
| Krop Julie (SVP Clinical & Regulatory, CMO) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Paid exercise price by delivering 2,394 shares
@ $22.13, valued at
$53k
|
|